Add to watchlist
Back to selection

 

60033-01 - Lecture: Special Topics in Drug Discovery and Development (2 CP)

Semester fall semester 2025
Course frequency Every fall sem.
Lecturers Tobias Junt (tobias.junt@unibas.ch)
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch)
Alex Odermatt (alex.odermatt@unibas.ch)
Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, Assessor)
Content Disease-based molecular knowledge as prerequisite for identifying novel medications in preclinical and clinical settings (cf lecture content on ADAM, Special Topics DDD)
Start-ups, big pharma and academic research as drivers of innovative drug-based therapies
AI as potential game-changer in pharmaceutical sciences
Natural compounds as starting points for efficacious therapies
Peptidic drugs as highly potent endocrine modulators
Digital platforms and novel analytical procedures enhancing the potential of biomarkers
Antifungal approaches and their limiting adverse effects
New developments e.g. in the treatment of Alzheimer's
Role of drug agencies in drug development

Learning objectives Learn from current drug research activities in start-ups, big pharma and academic research
Bibliography For details and literature see ADAM
Weblink Department of Pharmaceutical Sciences

 

Admission requirements
This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch
Course application This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch
Language of instruction English
Use of digital media No specific media used

 

Interval Weekday Time Room
wöchentlich Monday 10.15-12.00 Biozentrum, Seminarraum U1.191

Dates

Date Time Room
Monday 15.09.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 22.09.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 29.09.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 06.10.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 13.10.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 20.10.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 27.10.2025 10.15-12.00 no lecture, exam week
Monday 03.11.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 10.11.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 17.11.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 24.11.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 01.12.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 08.12.2025 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 15.12.2025 10.15-12.00 no lecture, exam week
Modules Doctorate Pharmaceutical Sciences: Recommendations (PhD subject: Pharmaceutical Sciences)
Doctorate Toxicology: Recommendations (PhD subject: Toxicology)
Electives Master Science in Pharmacy: Recommendations (Master's Studies: Pharmacy)
Module Specialisation: Medical Nanosciences (Master's Studies: Nanosciences)
Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences)
Assessment format continuous assessment
Assessment details Compulsary 100% attendance and presentations by all students. More details will be communicated during the first lecture.
Assessment registration/deregistration Reg.: course registration, dereg: cancel course registration
Repeat examination no repeat examination
Scale Pass / Fail
Repeated registration as often as necessary
Responsible faculty Faculty of Science, studiendekanat-philnat@unibas.ch
Offered by Departement Pharmazeutische Wissenschaften

Back to selection